Analyzing Retractable Technologies (NYSE:RVP) & Nemaura Medical (OTCMKTS:NMRD)

Earnings & Valuation

This table compares Retractable Technologies and Nemaura Medical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$38.27 million	0.54	-$7.01 million	($0.42)	-1.64
Nemaura Medical	N/A	N/A	N/A	($0.50)	0.00

Nemaura Medical has lower revenue, but higher earnings than Retractable Technologies. Retractable Technologies is trading at a lower price-to-earnings ratio than Nemaura Medical, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 4.4% of Nemaura Medical shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by insiders. Comparatively, 40.4% of Nemaura Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Retractable Technologies and Nemaura Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Nemaura Medical	N/A	N/A	N/A

Volatility and Risk

Retractable Technologies has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.18, indicating that its share price is 82% less volatile than the S&P 500.

Summary

Retractable Technologies beats Nemaura Medical on 5 of the 9 factors compared between the two stocks.

About Retractable Technologies

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

About Nemaura Medical

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.